Sommaire

• • ·Hippocrates and cardiology

    Page :173-183

    Tsung O. Cheng

    Résumé Résumé
• • ·Different expressivity of a ventricular essential myosin light chain gene Ala57Gly mutation in familial hypertrophic cardiomyopathy

    Page :184-189

    Won-Ha Lee, Tae Hong Hwang, Akinori Kimura, Seung Woo Park, Manatsu Satoh, Hirofumi Nishi, Haruhito Harada, Junji Toyama, Jeong-Euy Park

    Résumé Résumé
• • ·Rationale and design of the GRACE (Global Registry of Acute Coronary Events) Project: A multinational registry of patients hospitalized with acute coronary syndromes

    Page :190-199

    Résumé Résumé
• • ·Characterization and clinical course of patients not receiving aspirin for acute myocardial infarction: Results from the MITRA and MIR studies

    Page :200-205

    Birgit Frilling, Rudolf Schiele, Anselm Kai Gitt, Ralf Zahn, Steffen Schneider, Hans-Georg Glunz, Ulf Gieseler, Bernd Baumgärtel, Frank Asbeck, Jochen Senges, for the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) and the Myocardial Infarction Registry (MIR) Study Groups

    Résumé Résumé
• • ·C-reactive protein is not associated with the presence or extent of calcified subclinical atherosclerosis

    Page :206-210

    Marc E. Hunt, Patrick G. O'Malley, Marina N. Vernalis, Irwin M. Feuerstein, Allen J. Taylor

    Résumé Résumé
• • ·Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome

    Page :211-217

    Yoichi Inokubo, Hiroyuki Hanada, Hiroshi Ishizaka, Tomohisa Fukushi, Takaatsu Kamada, Ken Okumura

    Résumé Résumé
• • ·Bleeding risks with abciximab after full-dose thrombolysis in rescue or urgent angioplasty for acute myocardial infarction

    Page :218-225

    Philip Jong, Eric A. Cohen, Wayne Batchelor, Charles Lazzam, Catherine Kreatsoulas, Madhu K. Natarajan, Bradley H. Strauss

    Résumé Résumé
• • ·Rapid assessment of glycoprotein IIb/IIIa blockade with the platelet function analyzer (PFA-100) during percutaneous coronary intervention

    Page :226-233

    Mina Madan, Scott D. Berkowitz, Douglas J. Christie, Lisa K. Jennings, Astrid C. Smit, Kristina N. Sigmon, Steven Glazer, James E. Tcheng

    Résumé Résumé
• • ·Regional wall stress predicts ventricular remodeling after anteroseptal myocardial infarction in the Healing and Early Afterload Reducing Trial (HEART): An echocardiography-based structural analysis

    Page :234-242

    Yumiko Aikawa, Luis Rohde, Jonathan Plehn, Sally C. Greaves, Francis Menapace, J.Malcolm O. Arnold, Jean-Lucien Rouleau, Marc A. Pfeffer, Richard T. Lee, Scott D. Solomon

    Résumé Résumé
• • ·Contrast echocardiography for detection of pulmonary arteriovenous malformations

    Page :243-246

    K. Nanthakumar, A.T. Graham, T.I. Robinson, P. Grande, R.A. Pugash, J.A. Clarke, S.J. Hutchison, J.L. Mandzia, R.H. Hyland, M.E. Faughnan

    Résumé Résumé
• • ·Evidence of cardiac myolysis in severe nonischemic heart failure and the potential role of increased wall strain

    Page :247-253

    Damien Logeart, Pascale Beyne, Christine Cusson, Maria Tokmakova, Monique Leban, Chabnam Guiti, Pierre Bourgoin, Alain Cohen Solal

    Résumé Résumé
• • ·Heart failure disease management in an indigent population

    Page :254-258

    Aurelia M. O'Connell, Michael H. Crawford, Jonathan Abrams

    Résumé Résumé
• • ·Pharmacodynamic effects of milrinone with and without a bolus loading infusion

    Page :266-273

    Lawrence Baruch, Proserfino Patacsil, Ameer Hameed, Ileana Pina, Evan Loh

    Résumé Résumé
• • ·Improved survival of patients with acute myocardial infarction with significant left ventricular dysfunction undergoing invasive coronary procedures

    Page :267-276

    David Rott, Solomon Behar, Hanoch Hod, Micha S. Feinberg, Valentina Boyko, Lori Mandelzweig, Elieser Kaplinsky, Shmuel Gottlieb, for the Argatroban in Acute Myocardial Infarction-2 (ARGAMI-2) Study Group*

    Résumé Résumé
• • ·Increased plasma adhesion molecule levels in patients with heart failure who have ischemic heart disease and dilated cardiomyopathy

    Page :277-280

    Dimitris Tousoulis, Homeyra Homaei, Nabeel Ahmed, George Asimakopoulos, Emmanouil Zouridakis, Pavlos Toutouzas, Graham J. Davies

    Résumé Résumé
• • ·Formal analysis of the optimal duration of tilt testing for the diagnosis of neurally mediated syncope

    Page :282-288

    Kenneth M. Stein, David J. Slotwiner, Suneet Mittal, Marc Scheiner, Steven M. Markowitz, Bruce B. Lerman

    Résumé Résumé
• • ·Procedures of Data and Safety Monitoring Committees

    Page :289-294

    Stuart Pocock, Curt D. Furberg

    
• • ·Making changes in clinical trials

    Page :295-300

    W.Douglas Weaver, Sally Greenberg

    
• • ·Statistical approaches and policies for the operations of Data and Safety Monitoring Committees

    Page :301-305

    Robert M. Califf, Susan S. Ellenberg

    
• • ·Highlights from the American Heart Association Annual Scientific Sessions 2000: November 12 to 15, 2000

    Page :306-318

    J.Conor O’Shea, M.Cecilia Bahit, Thaddeus R. Tolleson, Christopher Cabell, Christopher K. Dyke, Aditya Kaul, Darren K. McGuire, Mark A. East

    
• • ·Effect of metoprolol on rest and exercise left ventricular systolic and diastolic function in idiopathic dilated cardiomyopathy

    Page :E5

    Ian P. Clements, Wayne L. Miller

    Résumé Résumé
• • ·Parasympathetic dysautonomia precedes left ventricular systolic dysfunction in Chagas disease

    Page :E6

    Antonio L.P. Ribeiro, Ruy S. Moraes, Jorge P. Ribeiro, Elton L. Ferlin, Rosália M. Torres, Enilce Oliveira, Manoel O.C. Rocha

    Résumé Résumé
• • ·An angiotensin-converting enzyme inhibitor improves left ventricular systolic and diastolic function in transfusion-dependent patients with β-thalassemia major

    Page :E7

    Haralambos I. Karvounis, Theodora A. Zaglavara, Georgios E. Parharidis, Ioannis G. Nouskas, Eleni P. Hassapopoulou, Konstantinos D. Gemitzis, Georgios E. Louridas

    Résumé Résumé